MondayAug 30, 2010 1:50 pm

GoSolarUSA Inc. (GSLO.PK) is “One to Watch”

GoSolarUSA Inc. is focused on identifying, developing and manufacturing new solar energy technologies in the United States. They are working to advance clean American solar technology to compete in an industry sector that includes such companies as First Solar, Inc. (NASDAQ: FSLR). GoSolarUSA Inc. has their headquarters in New Orleans, Louisiana. GoSolarUSA Inc.’s President, Tyson Rohde, has years of investment banking and business development experience. He has served as the Chief Operating Officer and a director for Southfield Energy Corporation, assisting with the origination and management of oil and gas investments. Mr. Rohde was also the Chief Executive Officer and…

Continue Reading

MondayAug 30, 2010 10:54 am

China Pharmaceuticals Inc. (CFMI.OB) Posts Record Q2 Financials

China Pharmaceuticals Inc., a leading manufacturer and distributor of prescription and over-the-counter pharmaceuticals, today announced record financial results for its second quarter ended June 30, 2010. The company reported total revenue for the quarter of $10.44 million, up 105 percent from $5.08 million reported for the second quarter of 2009. Gross profit increased 89 percent to $6.08 million, up from $3.21 million reported for the comparable period of last year. Operating income grew 204 percent to $6.35 million as compared to $2.08 million reported for the second quarter ended June 30, 2009. China Pharmaceuticals’ net income increased 208 percent to…

Continue Reading

MondayAug 30, 2010 9:32 am

Samples of Revolutions Medical Corp.’s (RMCP.OB) RevVac Safety Syringe to be Completed and Ready for Distribution

Since acknowledgement of the successful completion of a Pilot Run for new manufacturing design changes to the RevVac Safety Syringe earlier in May, Revolutions Medical has been working closely with a U.S. manufacturer to complete market samples. Sporting the company's new label, these samples have only eight parts compared to twelve, enabling even better performance at lower cost. Now that the market samples are completed, Revolutions Medical can finalize negotiations with manufacturers and distributors. "Not only do I think we have the world's least expensive and best automatic retractable safety syringe, our manufacturing price could even be competitive with standard…

Continue Reading

MondayAug 30, 2010 9:03 am

Stock Guru Featured Company: Budget Center Inc. (BDGN.PK)

Budget Center maximizes the spectrum of offerings available to consumers (at every financial level) seeking travel and related services by leveraging an entire series of URL domains that all start with the key term “budget” (like the extremely promising budgethotels.com). By developing the budget brand of domains, in conjunction with strategic relationships which harness the inventories of the biggest and most well-known websites, BDGN is able to focus on dominating the online travel budget space without incurring the costs of such inventories. The idea of saving money on travel is as old as civilization itself and BDGN is looking to…

Continue Reading

MondayAug 30, 2010 8:58 am

Beacon Equity Research Featured Company: WebSafety, Inc. (WBSI.OB)

WebSafety understands the complexities and difficulties associated with parental control solutions for computers and cell phones. The company develops revolutionary, non-invasive products like WebSafetyPC and CellSafety to address child safety without infringing on privacy. Based on the world’s largest word recognition library, WBSI products can identify inappropriate content from sex-based texting and texting while driving, to pornography or online predators, and contact parents by email or cell phone with only the relevant or dangerous material. This ingenious methodology keeps parents aware by alerting them only when a danger is present, preserving the personal space kids demand while offering a security…

Continue Reading

MondayAug 30, 2010 8:55 am

IntelGenx Corp. (IGXT.OB) and RedHill Biopharma Ltd. Announce Agreement for Anti-Migraine Film Product

IntelGenx Corp. has focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems to separate themselves from the competition in the medical sector. Today, IntelGenx took a major step forward with the announcement that they have entered a definitive agreement with RedHill Biopharma for an Anti-Migraine film product. The product is intended for the rapid relief of migraines and will be the first oral thin film product based upon IntelGenx's proprietary VersaFilm technology. The terms of this co-development and commercialization agreement will have Red Hill obtaining certain exclusive rights to market and sell the…

Continue Reading

MondayAug 30, 2010 8:45 am

Uranium Energy Corp. (UEC) Announces Completion of First Phase of Wellfield Development at Palangana in South Texas

Uranium Energy Corp. was pleased to announce this morning that it has completed the first of three phases of wellfield development at Production Area One ("PAA-1") at the Palangana ISR uranium project located in South Texas. According to the press release, Uranium Energy completed 40 injection and production wells thus far, marking the end of Phase One in the development of PAA-1. The wells are to be brought on-stream in three approximately equivalent phases as part of the build-up to initial sustainable levels of production. Construction of Palangana's ion-exchange satellite facility is also underway with pumps and tanks to be…

Continue Reading

MondayAug 30, 2010 8:11 am

Forbes Medi-Tech (FMTI.OB) Closes Asset Sale and Updates Shareholders on Schedule of Liquidation

Forbes Medi-Tech, Inc. issued a press release after the closing bell on Friday to announce the closing of an asset sale in which the majority of its assets have been sold to Pharmachem Laboratories, Inc. In negotiation since July, this sale was previously announced as accepted on August 20, 2010 in which terms were reached at US$4.0 million. This dollar amount is significantly higher than the amount offered by MHT, LLC as announced in initial negotiations for an asset sale as announced in July. Pharmachem Laboratories is a U.S.-based manufacturer and supplier of ingredients, including nutritionals, food and beverages, flavors…

Continue Reading

FridayAug 27, 2010 4:05 pm

Cleveland BioLabs (CBLI) Poised to Capitalize Massively on Multiple Government Contracts for Radiation Countermeasures

Cleveland BioLabs, www.cbiolabs.com, is well-positioned as both a bio-defense and medical company, with proficiencies in radiation countermeasures, as well as preclinical cancer, stem cell and acute organ failure technologies. President and CEO of CBLI, Michael Fonstein, detailed excitement over CBLB502, the Company’s radiation countermeasure being favorably positioned to receive the final contract award by the DOD (pursuant to a Q1 FY10 Request For Proposal response). In an exclusive interview with BioMedReports, Fonstein revealed that the CBLB502 defense program is based on CBLI’s unique pharmacological approach of achieving radioprotectant (preventative) and radiation damage mitigation parameters via Protectans, molecules which shield the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered